Swedish e-pharmacy Apotea rang the bell at Nasdaq Stockholm on Dec. 6 to celebrate its initial public offering, marking the largest debut on Nasdaq’s European markets in 2024 by market capitalization. The IPO emphasizes the stability of Nordic markets at a time of uncertain conditions internationally and continues to demonstrate how …
Read More »